
The hikes come as drugmakers are reeling from effects of the COVID-19 pandemic, which has reduced doctor visits and demand for some drugs. They are also fighting new drug price cutting rules from the Trump administration, which would reduce the industry#39;s profitability.
from Moneycontrol Latest News https://ift.tt/350Wuh5
Comments
Post a Comment